Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Onconetix (ONCO) Depreciation & Amortization (CF) (2023 - 2025)

Onconetix (ONCO) has disclosed Depreciation & Amortization (CF) for 2 consecutive years, with $119299.0 as the latest value for Q4 2024.

  • On a quarterly basis, Depreciation & Amortization (CF) rose 205.5% to $119299.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $731345.0, a 1564.53% increase, with the full-year FY2024 number at $731345.0, up 1564.53% from a year prior.
  • Depreciation & Amortization (CF) was $119299.0 for Q4 2024 at Onconetix, down from $204045.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $206700.0 in Q1 2024 to a low of $1571.0 in Q2 2023.